Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Desiccated Thyroid Extract Combined With Levothyroxine for TSH Suppression Therapy in Intermediate-to-High Risk Differentiated Thyroid Cancer After Surgery: A National Multicenter, Open-Label, Randomized Controlled Trial

NCT07239674 is registered in ClinicalTrials.gov with West China Hospital as lead sponsor.

NCT NCT07239674
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07239674 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Desiccated Thyroid Extract Combined With Levothyroxine for TSH Suppression Therapy in Intermediate-to-High Risk Differentiated Thyroid Cancer After Surgery: A National Multicenter, Open-Label, Randomized Controlled Trial
Lead sponsor
West China Hospital
Phase
Phase 3
Overall status
Not yet recruiting
Start date
November 30, 2025
Completion date
June 30, 2028
Enrollment
646 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

intermediate-to-high risk differentiated thyroid cancer